Article Information
History
- May 2, 2021.
Article Versions
- Version 1 (April 30, 2021 - 07:21).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mahmoud M. Tolba1,2,*,
- Bangli Soliman2,3,
- Abdul Jabbar4,
- HebaT’Allah Nasser5 and
- Mahmoud Elhefnaw2,3
- 1Pharmaceutical Division, Ministry of Health and Population, Faiyum, Egypt
- 2Informatics and Systems Department, Division of Engineering research, National Research centre, Cairo 12622, Egypt
- 3Biomedical Informatics and Chemoinformatics Group, Centre of Excellence for medical research, National Research Centre, Cairo 12622, Egypt
- 4Department of Clinical Medicine, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, 54600, Lahore Punjab Pakistan
- 5Microbiology and Public Health Department, Faculty of Pharmacy and Drug Technology, Heliopolis University, Cairo, Egypt
- ↵Corresponding author: Mahmoud M. Tolba
, Email: mahmoud.tolba109{at}gmail.com
Posted May 02, 2021.
An in silico integrative analysis of hepatocellular carcinoma omics databases shows the dual regulatory role of microRNAs either as tumor suppressors or as oncomirs
